Cas no 1171927-51-7 (7-Bromo-1-benzothiophene-2-carbohydrazide)
7-Bromo-1-benzothiophene-2-carbohydrazide Chemical and Physical Properties
Names and Identifiers
-
- 7-Bromo-1-benzothiophene-2-carbohydrazide
-
- MDL: MFCD12032269
- Inchi: 1S/C9H7BrN2OS/c10-6-3-1-2-5-4-7(9(13)12-11)14-8(5)6/h1-4H,11H2,(H,12,13)
- InChI Key: RXTOVYNICYAXJN-UHFFFAOYSA-N
- SMILES: C12=C(Br)C=CC=C1C=C(C(NN)=O)S2
7-Bromo-1-benzothiophene-2-carbohydrazide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB418645-1 g |
7-Bromo-1-benzothiophene-2-carbohydrazide |
1171927-51-7 | 1 g |
€266.80 | 2023-07-19 | ||
| Apollo Scientific | OR110808-1g |
7-Bromo-1-benzothiophene-2-carbohydrazide |
1171927-51-7 | 1g |
£59.00 | 2025-02-19 | ||
| Chemenu | CM487227-1g |
7-Bromobenzo[b]thiophene-2-carbohydrazide |
1171927-51-7 | 97% | 1g |
$*** | 2023-04-03 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1512379-1g |
7-Bromobenzo[b]thiophene-2-carbohydrazide |
1171927-51-7 | 98% | 1g |
¥3263.00 | 2024-08-09 | |
| Ambeed | A250913-1g |
7-Bromobenzo[b]thiophene-2-carbohydrazide |
1171927-51-7 | 97% | 1g |
$351.0 | 2024-04-26 | |
| abcr | AB418645-1g |
7-Bromo-1-benzothiophene-2-carbohydrazide; . |
1171927-51-7 | 1g |
€144.80 | 2025-02-18 |
7-Bromo-1-benzothiophene-2-carbohydrazide Related Literature
-
Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
-
Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
-
Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
-
José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
-
Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
Additional information on 7-Bromo-1-benzothiophene-2-carbohydrazide
Recent Advances in the Study of 7-Bromo-1-benzothiophene-2-carbohydrazide (CAS: 1171927-51-7)
The compound 7-Bromo-1-benzothiophene-2-carbohydrazide (CAS: 1171927-51-7) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications in drug discovery and development. This heterocyclic compound, characterized by a benzothiophene core and a carbohydrazide functional group, has shown promising potential as a building block for the synthesis of bioactive molecules. Recent studies have explored its role in the development of novel therapeutic agents, particularly in the areas of oncology, infectious diseases, and neurological disorders.
One of the key areas of research involving 7-Bromo-1-benzothiophene-2-carbohydrazide is its application in the design of kinase inhibitors. Kinases are critical regulators of cellular signaling pathways, and their dysregulation is often implicated in cancer and other diseases. Researchers have synthesized a series of derivatives based on this scaffold and evaluated their inhibitory activity against various kinases. Preliminary results indicate that certain derivatives exhibit potent and selective inhibition, making them promising candidates for further preclinical development.
In addition to its role in kinase inhibition, 7-Bromo-1-benzothiophene-2-carbohydrazide has also been investigated for its antimicrobial properties. A recent study demonstrated that this compound and its analogs exhibit broad-spectrum activity against both Gram-positive and Gram-negative bacteria. The mechanism of action appears to involve disruption of bacterial cell wall synthesis, although further studies are needed to elucidate the precise molecular targets. These findings highlight the potential of this compound as a lead structure for the development of new antibiotics, particularly in the face of rising antibiotic resistance.
Another exciting avenue of research involves the use of 7-Bromo-1-benzothiophene-2-carbohydrazide in the synthesis of fluorescent probes. Due to its unique photophysical properties, this compound has been employed as a fluorophore in the development of sensors for detecting biologically relevant molecules, such as reactive oxygen species (ROS) and metal ions. These probes have applications in both basic research and clinical diagnostics, offering high sensitivity and specificity.
Despite these promising developments, challenges remain in the optimization of 7-Bromo-1-benzothiophene-2-carbohydrazide-based compounds. Issues such as solubility, bioavailability, and off-target effects need to be addressed to fully realize their therapeutic potential. Future research directions may include structural modifications to improve pharmacokinetic properties, as well as in-depth mechanistic studies to better understand their interactions with biological targets.
In conclusion, 7-Bromo-1-benzothiophene-2-carbohydrazide (CAS: 1171927-51-7) represents a valuable scaffold in medicinal chemistry with diverse applications. Its versatility in drug design, antimicrobial activity, and utility in fluorescent probe development underscore its importance in contemporary research. Continued exploration of this compound and its derivatives is likely to yield significant advancements in the field of chemical biology and pharmaceutical sciences.
1171927-51-7 (7-Bromo-1-benzothiophene-2-carbohydrazide) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)